A phase I safety and pharmacokinetic (PK) study of navitoclax (N) in combination with docetaxel (D) in patients (pts) with solid tumors

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 29; no. 15_suppl; p. 2518
Main Authors	Puglisi, M., van Doorn, L., Blanco-Codesido, M., De Jonge, M. J., Moran, K., Yang, J., Busman, T., Franklin, C., Mabry, M., Krivoshik, A., Humerickhouse, R., Molife, L. R., Eskens, F.
Format	Journal Article
Language	English
Published	20.05.2011
Online Access	Get full text

Loading…